149 results on '"Palumbo-Zerr, Katrin"'
Search Results
2. SYNTA: A novel approach for deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data
3. PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass
4. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis
5. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
6. Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease
7. Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease
8. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
9. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis
10. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
11. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
12. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
13. Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
14. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
15. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
16. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
17. Cardiomyopathy in Murine Models of Systemic Sclerosis
18. The Nuclear Receptor Constitutive Androstane Receptor/NR1I3 Enhances the Profibrotic Effects of Transforming Growth Factor β and Contributes to the Development of Experimental Dermal Fibrosis
19. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
20. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
21. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
22. Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
23. Impaired Vitamin D Receptor Signaling Upregulates Transforming Growth Factor Beta (TGFβ) Signaling In Systemic Sclerosis.: 1690
24. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
25. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
26. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
27. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
28. Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
29. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
30. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
31. NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover
32. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis
33. JAK2 as a novel mediator of the pro-fibrotic effects of TGFβ in systemic sclerosis
34. Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc)
35. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
36. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis
37. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
38. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
39. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
40. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
41. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
42. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
43. Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
44. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
45. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
46. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
47. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
48. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
49. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.
50. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-[beta] signalling to prevent fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.